title: Organotypic liver culture models: meeting current challenges in toxicity testing.
abstract: Prediction of chemical-induced hepatotoxicity in humans from in vitro data continues to be a significant challenge for the pharmaceutical and chemical industries. Generally, conventional in vitro hepatic model systems (i.e. 2-D static monocultures of primary or immortalized hepatocytes) are limited by their inability to maintain histotypic and phenotypic characteristics over time in culture, including stable expression of clearance and bioactivation pathways, as well as complex adaptive responses to chemical exposure. These systems are less than ideal for longer-term toxicity evaluations and elucidation of key cellular and molecular events involved in primary and secondary adaptation to chemical exposure, or for identification of important mediators of inflammation, proliferation and apoptosis. Progress in implementing a more effective strategy for in vitro-in vivo extrapolation and human risk assessment depends on significant advances in tissue culture technology and increasing their level of biological complexity. This article describes the current and ongoing need for more relevant, organotypic in vitro surrogate systems of human liver and recent efforts to recreate the multicellular architecture and hemodynamic properties of the liver using novel culture platforms. As these systems become more widely used for chemical and drug toxicity testing, there will be a corresponding need to establish standardized testing conditions, endpoint analyses and acceptance criteria. In the future, a balanced approach between sample throughput and biological relevance should provide better in vitro tools that are complementary with animal testing and assist in conducting more predictive human risk assessment.
authors.affiliation: The Institute for Chemical Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, NC, USA. elecluyse@thehamner.org
authors.forename: Edward L
authors.initials: EL
authors.lastname: LeCluyse
authors.forename: Rafal P
authors.initials: RP
authors.lastname: Witek
authors.forename: Melvin E
authors.initials: ME
authors.lastname: Andersen
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Powers
mesh_terms: D000818:Animals; D018929:Cell Culture Techniques; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004345:Drug Industry; D006439:Hemodynamics; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D018570:Risk Assessment / Q000379:methods; D046509:Tissue Culture Techniques; D018675:Toxicity Tests / Q000379:methods*